Table 1 (abstract A59). Medication Use Documented at Baseline Visit of Patients with SLE and Related Conditions in the CARRA Registry (n=380)
Medication | n (%) |
|---|---|
Hydroxychloroquine | 336 (88%) |
Oral Prednisone | 232 (61%) |
Mycophenolate mofetil/Mycophenolic Acid | 161 (42%) |
Methotrexate | 63 (17%) |
Cyclophosphamide | 49 (13%) |
Azathioprine | 50 (13%) |
Rituximab | 47 (12%) |
Belimumab | 4 (1%) |